Analyses note that the piece relies on historical data and forecasts and may not reflect the latest company announcements; it is general in nature and not financial advice.

A strong order-intake pipeline underpins the valuation case, with backlogs estimated in the €80–€120 billion range by mid-2025/2026.

The United States is pursuing co-production of Raytheon AIM-120 AMRAAM missiles and a maintenance facility for Lockheed Martin's PAC-3 Patriot missiles in Europe, aiming to build a resilient regional defense-industrial base.

The plan targets reducing European supply vulnerabilities and strengthening long-range strike and air-defence capabilities by creating Europe-based production, integration, and distribution for these systems within NATO.

The stock has fallen sharply this year, down about 31%, and roughly 39% over the past year, though a three-year view shows substantial gains.

Discussions occur amid U.S. concerns about weapon stock availability due to conflicts in Ukraine and Iran, accelerating moves to expand domestic and allied production.

The bullish thesis depends on sustained European defense spending, successful capacity expansions, and avoiding cost overruns or delays, with risks tied to spending support and implementation timelines.

High demand for PAC-3 and AIM-120 missiles in Ukraine underpins the push for regionalized production, given Kyiv’s reliance on Western air defenses amid the ongoing conflict.

A frame contract for the project is expected to be signed by year-end, with production beginning in about two years.

Ukraine’s ongoing need for Patriot PAC-3 and AIM-120C-8 missiles (used by NASAMS and F-16s) is a key driver of interest in a European production footprint.

A Rheinmetall Unterlüß facility would become Europe’s first center for ATACMS production, integration, and distribution for NATO and allied users, boosting readiness and interoperability.

Other defense and critical-infrastructure ideas are noted for investors, including high-quality value picks, dividends, and low-risk leaders, though these are informational rather than recommendations.